Vaccines against 'the other' Ebolavirus species (Q40112699)

17 September 2017

Vaccines against 'the other' Ebolavirus species (English)

1 reference

17 September 2017

2

Gary P Kobinger

1 reference

17 September 2017

Robert A Kozak

1

1 reference

17 September 2017

24 March 2016

1 reference

Expert Review of Vaccines

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

9

1 reference

17 September 2017

1093-1100

1 reference

Inactivated vaccine for Ebola virus efficacious in guineapig model

17 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Evaluation in nonhuman primates of vaccines against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Biological warfare, bioterrorism, and biocrime

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Evaluation of perceived threat differences posed by filovirus variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebolavirus Evolution: Past and Present

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Filoviruses: One of These Things is (not) Like the Other

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Emergence of Zaire Ebola Virus Disease in Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

What factors might have led to the emergence of Ebola in West Africa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebola and Marburg haemorrhagic fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

The multiple roles of sGP in Ebola pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Epitopes involved in antibody-mediated protection from Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebola virus disease outbreak in Nigeria: Transmission dynamics and rapid control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Viral bioterrorism: Learning the lesson of Ebola virus in West Africa 2013-2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Backs against the wall: novel and existing strategies used during the 2014-2015 Ebola virus outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Clinical development of Ebola vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, doub

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Implementation of an Ebola virus disease vaccine clinical trial during the Ebola epidemic in Liberia: Design, procedures, and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Reemerging Sudan Ebola virus disease in Uganda, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Development and Characterization of a Guinea Pig-Adapted Sudan Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebola Virus Disease Outbreak in Isiro, Democratic Republic of the Congo, 2012: Signs and Symptoms, Management and Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Molecular evidence of Ebola Reston virus infection in Philippine bats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

A seroepidemiologic study of Reston ebolavirus in swine in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Analysis of the humoral immune responses among cynomolgus macaque naturally infected with Reston virus during the 1996 outbreak in the Philippines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Discovery of swine as a host for the Reston ebolavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebola Reston virus infection of pigs: clinical significance and transmission potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Isolation and partial characterisation of a new strain of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

A serological survey of Ebola virus infection in central African nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Ebola virus outbreak among wild chimpanzees living in a rain forest of Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Emergency postexposure vaccination with vesicular stomatitis virus-vectored Ebola vaccine after needlestick

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2016.1170597

10.1586/14760584.2016.1170597

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference

PubMed ID

27010528